-The Times of India MUMBAI: Some multinational companies (MNCs) have been delaying the launch of life-saving drugs in India years after getting monopoly rights, while cheaper generic versions of exorbitantly-priced medicines are going off the shelves under the product patenting law. Corporates such as Japanese firm Otsuka Pharmaceuticals, US-based Bristol Myers-Squibb (BMS) and Swiss firm Novartis are deferring the launch of medicines critical for treatment of serious non-communicable diseases like cancer, HIV,...

-The Hindu The deaths of Chaiti Bai and other women after a botched tubectomy in Chhattisgarh are an opportunity to reflect on the problems India faces in the pursuit of modernity and global status, especially in health and education A sudden death always has great pedagogical value. The death of Chaiti Bai, a Baiga tribal woman, following a botched tubectomy at a mass sterilisation camp in Chhattisgarh recently, can improve our perspective...

-The Pioneer The Modi Government has set March 2017 deadline to provide safe drinking water in country's 17,995 habitations where rural people are being forced to consume contaminated water - laced with fluoride, arsenic and heavy toxic metals - causing major health problems. To achieve this, the Union Ministry of Water and Sanitation has outlined a two-pronged strategy entailing installation of community water purification plants or through piped water supply from alternate...

-The Hindu The government must recognise the role low-cost health IT innovations could play in improving diagnostic accuracy, including many that would be useful for rural India The diagnosis of the first patient with Ebola in the U.S. was initially missed in an emergency room late night on September 25. Thomas Duncan, a Liberian national visiting Dallas, Texas, complained of flu-like symptoms and fever, but after lab work and CT scans, was...

-Economic and Political Weekly The National Democratic Alliance government has constituted the IPR Think Tank which, among other things, is to draft the National Intellectual Property Rights Policy. India may not have a policy per se but it has a strong legislation on IPRs, a functioning patents office and mechanisms to grant patents as well as protect consumer interests. The Think Tank has other issues it needs to address, but is...